The stock of Rocket Lab USA has become a focal point of discussion among Wall Street traders this week, fueled by a significant shift in analyst sentiment. The central question now is how much additional momentum a single upgrade can provide for a stock that has already seen substantial gains.
Record Highs and Trading Activity
Trading activity for Rocket Lab shares was notably vigorous, with the stock posting a clear advance during the session. This move was accompanied by a sharp increase in trading volume and a pronounced dominance of call options, signaling strong short-term bullish sentiment among investors. As of the Friday close, the share price stood at $90.76, marking a record level and trading just shy of its 52-week high.
Morgan Stanley Shifts to Overweight
The catalyst for the recent movement was a decisive rating change from Morgan Stanley. The investment bank upgraded its stance on Rocket Lab from “Equal-Weight” to “Overweight,” citing the company’s growing market acceptance as a strategically vital space infrastructure player with considerable long-term potential.
Analysts at the firm highlighted two core strengths:
* A demonstrated track record of launch reliability.
* A concrete roadmap for entering the lucrative medium-lift launch market.
This optimistic reassessment arrives amidst a mixed landscape of analyst opinions. While KeyBanc recently downgraded the stock to “Sector Weight,” other firms like Needham and Cantor Fitzgerald have reaffirmed their positive outlooks following the company’s operational successes. Morgan Stanley’s move now provides a strong counterpoint, significantly bolstering the bullish camp.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
Fundamental Catalysts: A Major Contract and Record Revenue
The timing of the upgrade is not coincidental, as it follows several fundamental achievements by the company. Late in 2025, Rocket Lab secured its largest contract to date from the U.S. Space Development Agency (SDA). Valued at approximately $816 million, the deal involves the design and construction of 18 satellites, firmly establishing Rocket Lab as a key contractor within the U.S. defense sector.
This major award complemented an already robust operational environment. For the third quarter of 2025, the company reported record revenue, further reinforcing confidence in its business model. Consequently, the share price has been on a pronounced upward trajectory since mid-October 2025.
The stock’s performance reflects not only company-specific successes but also broader enthusiasm for the space sector. Many investors are betting on increased launch activity and supportive government policies in 2026. The equity’s powerful ascent over the past twelve months and its significant premium to medium-term average prices underscore the dynamism of this trend.
Looking Ahead: Key Milestones on the Horizon
Two specific near-term catalysts are now coming into focus for investors. First is the inaugural launch of the company’s larger, reusable Neutron rocket, which is anticipated in the first quarter of 2026. This milestone is viewed as critical for expanding access to the medium-payload market and strengthening Rocket Lab’s competitive position.
Second, the market awaits the next set of financial results. Around February 26, 2026, Rocket Lab is scheduled to release its fourth-quarter and full-year 2025 earnings. This report will reveal whether the company can operationally substantiate the recent tailwinds from the major contract, record revenue, and analyst upgrade—and if the stock’s current lofty valuation has a sustainable foundation.
Ad
Rocket Lab USA Stock: Buy or Sell?! New Rocket Lab USA Analysis from January 17 delivers the answer:
The latest Rocket Lab USA figures speak for themselves: Urgent action needed for Rocket Lab USA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 17.
Rocket Lab USA: Buy or sell? Read more here...








